Updated:
Kleiner Perkins
Kleiner Perkins, the venture firm founded by Eugene Kleiner and Tom Perkins, backed Google, Amazon, and Genentech under John Doerr's long tenure.
Kleiner Perkins
Eugene Kleiner, a Fairchild Semiconductor co-founder, and Tom Perkins, a Hewlett-Packard veteran, established Kleiner Perkins in 1972 with a template that became the Valley standard: technologist founders, professional board-building, and patient capital. The firm rode successive technology waves from semiconductors to genomics, famously incubating Genentech and commercializing the recombinant DNA technology that created the biotech industry. The partnership deploys across early-stage and growth-stage venture, with dedicated funds for climate and health sciences. Noted portfolio exposures have included Google, Amazon, Stripe, Slack, and Uber, alongside more recent wagers on Figma, Rippling, and Viz.ai. The operational model has evolved from the legendary "KP recruiting machine" of the dot-com era to a tighter, seed-conviction strategy led by Mamoon Hamid and Ilya Fushman — the duo who joined from Social Capital in 2018 and now anchor the firm's enterprise practice from Menlo Park. Kleiner Perkins operates select funds, including the climate-focused KP Energy Fund and a health sciences franchise, alongside its flagship venture vehicles. While total capital or deployment figures are not publicly disclosed, the firm's reputation rests on capitalizing breakthrough ideas with concentrated check sizes rather than scaling a large asset-gathering operation. Its 2023 fundraise for KP XXI targeted a reported $2 billion (per the Financial Times, 2023). The structural differentiator is the firm's selective pivot from a multi-stage, multi-sector generalist brand to a partner-led, high-conviction early-stage platform — a silhouette that mirrors the initial Kleiner-Perkins partnership era more than the expansive 2000s-era KPCB structure. This deliberate regression to founder-density over fund-size, managed by fewer investment leaders, defines the current posture.
General information
Firm type
Venture Capital
Year founded
1972
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Principals
John Doerr
Chairman
Mamoon Hamid
Managing Partner
Ilya Fushman
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Kleiner Perkins?
Mamoon Hamid and Ilya Fushman, both Managing Partners, lead the firm's core venture practice from Menlo Park. John Doerr remains Chairman. Decision-making has consolidated under the Hamid-Fushman partnership since their 2018 arrival from Social Capital, reducing the broad committee model of the prior decade.
Is Kleiner Perkins structured as a venture firm or does it operate additional strategies?
The firm remains a traditional venture capital partnership but runs distinct funds for health sciences and climate. The health sciences effort traces lineage to Brook Byers' Genentech-era investing; the climate practice operates through a dedicated team making early-stage energy and sustainability bets.
Which investment stages does Kleiner Perkins target today?
The current strategy privileges early-stage, seed, and Series A investing, with selective growth-stage follow-ons. Under Hamid and Fushman, the partnership has publicly stated a preference for concentrated conviction over the spray-and-pray approach that characterized many large venture firms in the 2010s.
What is Kleiner Perkins' known posture on co-investments with external managers?
Kleiner Perkins generally leads or co-leads its deals and does not operate as a passive co-investor. The partnership builds syndicates on a deal-by-deal basis but typically seeks board seats and active influence, consistent with its heritage as a founder-level venture firm.
Does Kleiner Perkins maintain any philanthropic or non-investment structures?
John Doerr operates a separate philanthropic vehicle through the Benificus Foundation and has signed the Giving Pledge. The firm itself does not manage a donor-advised fund or foundation, maintaining a clean separation between its venture capital operations and individual partners' charitable activities.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: